Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|September 24, 2004
Akt: a potential target for thyroid cancer therapyFaiza Kada, Motoyasu Saji, Matthew D Ringel
Biochemical and Biophysical Research Communications|May 18, 2005
Akt1 contains a functional leucine-rich nuclear export sequenceMotoyasu Saji, Vasily Vasko, Faiza Kada, et al.
Molecular and Cellular Endocrinology|November 10, 2009
The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumorsMotoyasu Saji, Matthew D Ringel
Endocrinology|September 2, 2006
AKT in thyroid tumorigenesis and progressionMotoo Shinohara, Yun Jae Chung, Motoyasu Saji, et al.
Human Molecular Genetics|February 7, 2017
Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cellsWanfeng Yu, Ying Ni, Motoyasu Saji, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levelsMilena Braga-Basaria, Elena Hardy, Robert Gottfried, et al.
EMBO Reports|May 9, 2009
Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1Kiran S Nadella, Motoyasu Saji, Naduparambil K Jacob, et al.
Molecular Cancer Research : MCR|February 28, 2015
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes "microRNA-like" tRNA FragmentsNicole Guzman, Kitty Agarwal, Dilip Asthagiri, et al.
Endocrine-Related Cancer|September 7, 2010
Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasionSamantha K McCarty, Motoyasu Saji, Xiaoli Zhang, et al.
Endocrine-Related Cancer|May 31, 2019
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibitionChristina M Knippler, Motoyasu Saji, Neel Rajan, et al.
Pageof 16